Skip to main content
Figure 1 | AIDS Research and Therapy

Figure 1

From: Virologic and immunologic outcome of HAART in Human Immunodeficiency Virus (HIV)-1 infected patients with and without tuberculosis (TB) and latent TB infection (LTBI) in Addis Ababa, Ethiopia

Figure 1

Changes in HIV RNA level (copies/ml) over time after the start of HAART. HIV RNA was measured at baseline, at ART start and at six month (M6), M18 and M24 of HAART in HIV patients with TB (HIV + TB+) (continuous line) and without TB (HIV + TB-) (dotted line) (A), and HIV + TB- patients sub-grouped as those with TST positive (HIV + TST+) (continuous line) and TST negative (HIV + TST-) (dotted line) (B). Values are shown as mean and standard deviation. n = number of participants per visit.

Back to article page